An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon.
Acetylcholinesterase (EC 3.1.1.7) and butyrylcholinesterase (EC 3.1.1.8) are enzymes that belong to the superfamily of alpha/beta-hydrolase fold proteins. While they share many characteristics, they also possess many important differences. For example, whereas they have about 54% amino acid sequence identity, the active site gorge of acetylcholinesterase is considerably smaller than that of butyrylcholinesterase. Moreover, both have been shown to display simple and complex kinetic mechanisms, depending on the particular substrate examined, the substrate concentration, and incubation conditions. In the current study, incubation of butyrylthiocholine in a concentration range of 0.005-3.0 mM, with 317 pM human butyrylcholinesterase in vitro, resulted in rates of production of thiocholine that were accurately described by simple Michaelis-Menten kinetics, with a K(m) of 0.10 mM. Similarly, the inhibition of butyrylcholinesterase in vitro by the organophosphate chlorpyrifos oxon was described by simple Michaelis-Menten kinetics, with a k(i) of 3048 nM(-1) h(-1), and a K(D) of 2.02 nM. In contrast to inhibition of butyrylcholinesterase, inhibition of human acetylcholinesterase by chlorpyrifos oxon in vitro followed concentration-dependent inhibition kinetics, with the k(i) increasing as the inhibitor concentration decreased. Chlorpyrifos oxon concentrations of 10 and 0.3 nM gave k(i)s of 1.2 and 19.3 nM(-1) h(-1), respectively. Although the mechanism of concentration-dependent inhibition kinetics is not known, the much smaller, more restrictive active site gorge of acetylcholinesterase almost certainly plays a role. Similarly, the much larger active site gorge of butyrylcholinesterase likely contributes to its much greater reactivity towards chlorpyrifos oxon, compared to acetylcholinesterase.
Shenouda
Josephine
J
Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Green
Paula
P
Sultatos
Lester
L
D000110:Acetylcholinesterase / Q000737:chemistry*; D000122:Acetylthiocholine / Q000737:chemistry; D002091:Butyrylcholinesterase / Q000737:chemistry*; D002092:Butyrylthiocholine / Q000737:chemistry; D004390:Chlorpyrifos / Q000031:analogs & derivatives* / Q000737:chemistry; D002800:Cholinesterase Inhibitors / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007700:Kinetics
D002800:Cholinesterase Inhibitors; D000122:Acetylthiocholine; D002092:Butyrylthiocholine; C009618:O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; D000110:Acetylcholinesterase; D002091:Butyrylcholinesterase; D004390:Chlorpyrifos
Neurochem Res. 1992 Dec;17(12):1207-10
1461367
Nat Rev Neurosci. 2003 Feb;4(2):131-8
12563284
J Biol Chem. 2003 Oct 17;278(42):41141-7
12869558
J Biol Chem. 2000 Apr 21;275(16):11603-9
10766776
Biochem Pharmacol. 1961 Jul;7:88-95
13726518
Biochim Biophys Acta. 2002 Feb 11;1594(2):313-24
11904227
Chem Biol Interact. 2008 Sep 25;175(1-3):343-5
18541229
Toxicol Sci. 2006 Apr;90(2):460-9
16403852
Toxicol Sci. 2007 Nov;100(1):128-35
17702992
Biochemistry. 1995 Nov 28;34(47):15444-52
7492545
J Biol Chem. 1993 Aug 15;268(23):17083-95
8349597
Biochem J. 1989 Jan 15;257(2):419-24
2930459
Science. 1964 May 22;144(3621):992-3
14137949
Biochemistry. 1993 Jan 12;32(1):12-7
8418833
Eur J Biochem. 2004 Apr;271(7):1364-71
15030487
Biochim Biophys Acta. 2007 Sep;1774(9):1139-47
17690023
Chem Biol Interact. 1999 May 14;119-120:61-9
10421439
EMBO J. 1992 Oct;11(10):3561-8
1396557
Chem Biol Interact. 2005 Dec 15;157-158:143-52
16256969
Biochim Biophys Acta. 2001 Jan 12;1544(1-2):166-76
11341926
Biochemistry. 1997 Feb 25;36(8):2266-77
9047329
Biochem Pharmacol. 1998 Aug 1;56(3):293-9
9744565
Biochemistry. 1993 Nov 16;32(45):12074-84
8218285
FEBS J. 2008 May;275(10):2617-31
18422653
Toxicol Appl Pharmacol. 2007 Jun 1;221(2):243-50
17467020
Pflugers Arch. 2000 Jan;440(Suppl 1):R118-R120
28008505
Biochim Biophys Acta. 1986 Mar 28;870(2):185-90
3955054
EMBO J. 2003 Jan 2;22(1):1-12
12505979
Eur J Biochem. 1996 Jan 15;235(1-2):36-48
8631355
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10827-31
1438284
Biochemistry. 2003 May 13;42(18):5438-52
12731886
Biochemistry. 1973 Jul 17;12(15):2940-5
4737014
Chem Biol Interact. 1999 May 14;119-120:85-97
10421442
Biochim Biophys Acta. 1999 Jan 11;1429(2):422-30
9989227
Trends Biochem Sci. 2003 Jul;28(7):361-8
12878003
Chem Biol Interact. 2008 Sep 25;175(1-3):410-2
18602377
EMBO J. 2006 Jun 21;25(12):2746-56
16763558
J Biol Chem. 1987 Jan 15;262(2):549-57
3542989
Toxicol Appl Pharmacol. 2008 Aug 1;230(3):390-6
18423506
Eur J Biochem. 2002 Feb;269(4):1154-61
11856351
Eur J Biochem. 2003 Jan;270(2):315-24
12605682